Michael Cartmill

Michael Cartmill has extensive experience in the healthcare industry, with a focus on medical device development and clinical engineering. Michael currently serves as the Clinical and Data Lead at Vexev since March 2021. Previously, they worked as a Co-Founder and Medical Device Industry Specialist at Cordis Asset Management Pty Ltd starting from February 2020. Prior to that, they served as a Clinical Engineer at Procyrion, Inc. where they contributed to the design of real-time assessment methods and conducted computational fluid dynamics analysis. Michael also worked at Abiomed as a Senior Manager APAC, overseeing physician education and the commercial launch of the Impella device in the APAC region. During their tenure there, they developed a registry and conducted health economic modeling. Michael also obtained significant experience from their role at Abbott Vascular as an Asia Pacific Clinical and Technical Specialist/Product Manager, where they played a pivotal role in marketing and sales, revenue growth, and consulted with hospitals on pricing and purchasing strategies. Earlier in their career, they worked as a Clinical Applications Specialist at Philips Healthcare and as a Senior Cardiac Scientist-Imaging at King's College London.

Michael Cartmill obtained a Master of Business Administration (M.B.A.) degree in Innovation and Marketing from QUT (Queensland University of Technology) in 2015. Prior to that, they completed a Master's Degree in Information Technology also at QUT from 2013 to 2014. In 2012, they earned a Mit degree in Information Technology from Bond University. There is no information provided about their Bachelor's degree from James Cook University. Additionally, Michael Cartmill has obtained various certifications, including Medical Software from Yale University in 2022 and Multiple Linear Regression with scikit-learn from Coursera in 2020.